Spots Global Cancer Trial Database for Comparison Of 2 Doses Of Temsirolimus (Torisel) In Patients With Mantle Cell Lymphoma
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Comparison Of 2 Doses Of Temsirolimus (Torisel) In Patients With Mantle Cell Lymphoma
Official Title: A RANDOMIZED PHASE 4 STUDY COMPARING 2 INTRAVENOUS TEMSIROLIMUS (TEMSR) REGIMENS IN SUBJECTS WITH RELAPSED, REFRACTORY MANTLE CELL LYMPHOMA
Study ID: NCT01180049
Conditions
Study Description
Brief Summary: This study will compare the effectiveness and safety of two different doses of temsirolimus (Torisel).
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Mercy Research Institute, Miami, Florida, United States
Veterans Affairs New Jersey Healthcare System-Hematology/Oncology Section (111), East Orange, New Jersey, United States
Mercy Clinic Oklahoma Communities dba Mercy Clinic Oncology/Hematology-McAuley, Oklahoma City, Oklahoma, United States
Mercy Hospital Oklahoma City-Oncology Infusion, Oklahoma City, Oklahoma, United States
Amy Shen, RPh, Seattle, Washington, United States
VA Puget Sound Health Care System, Seattle, Washington, United States
St George Hospital, Kogarah, New South Wales, Australia
Royal Adelaide Hospital, Adelaide, South Australia, Australia
Royal Hobart Hospital, Hobart, Tasmania, Australia
Box Hill Hospital, Box Hill, Victoria, Australia
The Alfred Hospital, Melbourne, Victoria, Australia
Fakultni nemocnice Kralovske Vinohrady, Praha 10, Czech Republic, Czechia
Fakultni nemocnice Kralovske Vinohrady, Praha 10, , Czechia
Vseobecna fakultni nemocnice v Praze, Praha 2, , Czechia
CHU de Nancy, Vandoeuvre les Nancy, , France
Klinik fuer Onkologie und Haematologie, Medizinische Klinik IV, Aachen, , Germany
Klinikum Johannes-Gutenberg -Universitaet, III. Medizinische Klinik und Poliklinik, Mainz, , Germany
Presidio Ferrarotto - A.O.U. - PoliclinicoVittorio Emanuele, Catania, , Italy
Dipartimento di Medicina Diagnostica, Clinica e di Sanità Pubblica, Modena, , Italy
Struttura Complessa di Ematologia, Dipartimento di Oncologia ed Ematologia-, Torino, , Italy
Severance Hospital, Yonsei University, Seoul, , Korea, Republic of
Samsung Medical Center, Seoul, , Korea, Republic of
Malopolskie Centrum Medyczne S.C., Krakow, , Poland
Institutul Clinic Fundeni Bucuresti, Sectia II Hematologie, Bucuresti, , Romania
Spitalul Clinic Coltea, Clinica de Hematologie, Bucuresti, , Romania
Spitalul Universitar de Urgenta Bucuresti, Clinica de Hematologie, Bucuresti, , Romania
Republican Clinical Oncology Dispensary of the Ministry of Healthcare of Tatarstan Republic, Kazan, , Russian Federation
GBOU VPO "First Saint-Petersburg State Medical University n.a. I.P.Pavlov", Saint-Petersburg, , Russian Federation
Institute of Pediatric Hematology and Transplantology R.M.Gorbacheva, Saint-Petersburg, , Russian Federation
Clinical Centre of Serbia,Clinic for Hematology, Belgrade, , Serbia
Oncology Institute of Vojvodina, Sremska Kamenica, , Serbia
Contact Details
Name: Pfizer CT.gov Call Center
Affiliation: Pfizer
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
